However, the knockdown or knockout of PTPRJ increased the ability of gastric cancer cells to grow and metastasize in vitro and in vivo, and suppression of PTPRJ expression resulted in poor clinical characteristics and a poor prognosis in patients with gastric cancer [45]. This evidence concerns the gene PTPRJ and gastric cancer.